CDKN2B and coronary atherosclerosis: Genome-wide analysis of patients with hereditary coronary atherosclerosis indicated that the 9p21.3 allele variant was associated with AS burden, and loss of cyclin-dependent kinase inhibitor 2B (CDKN2B) at this locus promotes vascular SMC apoptosis and aneurysm progression (74).